SMNR · Semnur Pharmaceuticals, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“As a result, management has concluded that the aforementioned conditions, among other things, raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the condensed consolidated financial statements are issued.”